August 5, 2021 01:19 PM EDT

Covid-19 manufacturing roundup: EMA clears 2 New England manufacturing sites for Covid-19 vaccine scale up; Incentives, tax breaks highlight South Korea's efforts to be vaccine powerhouse

The EMA has approved a scale-up of production of Moderna’s Covid-19 vaccine Spikevax at two New England sites.

If all goes according to plan, the …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 man­u­fac­tur­ing roundup: EMA clears 2 New Eng­land man­u­fac­tur­ing sites for Covid-19 vac­cine scale up; In­cen­tives, tax breaks high­light South Ko­re­a's ef­forts to be vac­cine pow­er­house